In Sep., appraisal activity of the 2nd “2017 ranking of Chinese drug brands with R&D strength” under the guidance of CPU, Chongqing Economic & Information Commission and CMEA and sponsorship of Yaozhi and Chinese Pharmacy was unveiled. The company was given the honorary title of “Top 10 Chinese pharmaceutical R&D brands in 2017”. It’s known that the WeChat voting activity of “the 2nd selecting your favorite drug R&D company” under the sponsorship of Yaozhi aroused attentions of the masses within short 10 days. Nearly 300 pharmaceutical enterprises attended it. Thus, the voters of more than 540 thousand and nearly 3 million PV was achieved. Besides, “the ranking of drug R&D brands in China in 2017” was evaluated. In recent years, the national related department has been vigorously encouraging pharmaceutical enterprises to make innovations in new drugs, which undoubtedly brings about opportunity for the domestic pharmaceutical enterprises to develop new drugs to facilitate the development of the whole industry. Under the joint efforts of all pharmaceutical enterprises in the past year, the list of pharmaceutical enterprises with the strongest R&D strength in 2017 has been finalized and the drug enterprises in the list naturally have reputation along with the “Top 50 in the ranking of pharmaceutical enterprises with strength in China in 2017”.